Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK13 | O15264 | 11/20 | 0.67 |
| ▸ | MAPK12 | P53778 | 11/20 | 0.67 |
| ▸ | MAPK11 | Q15759 | 11/20 | 0.67 |
| ▸ | MAPK14 | Q16539 | 11/20 | 0.67 |
| ▸ | RAF1 | P04049 | 8/20 | 0.67 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.57 |
| ▸ | GCGR | P47871 | 3/20 | 0.55 |
| ▸ | MGAM | O43451 | 1/20 | 0.54 |
| ▸ | BRAF | P15056 | 2/20 | 0.53 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30514842 | 1.00 | MAPK13 (0.67) | MAPK13MAPK12MAPK11MAPK14RAF1 | |
| SCHEMBL8114499 | 0.93 | MAPK13 (0.76) | MAPK13MAPK12MAPK11MAPK14RAF1 | |
| SCHEMBL15401233 | 0.88 | MAPK14 (0.68) | MAPK13MAPK12MAPK11MAPK14RAF1 | |
| SCHEMBL10078946 | 0.87 | MAPK13 (0.86) | MAPK13MAPK12MAPK11MAPK14RAF1 | |
| SCHEMBL1040038 | 0.87 | MAPK13 (0.67) | MAPK13MAPK12MAPK11MAPK14RAF1 | |
| SCHEMBL306063 | 0.87 | MAPK13 (0.67) | MAPK13MAPK12MAPK11MAPK14RAF1 | |
| SCHEMBL29360656 | 0.87 | MAPK13 (0.67) | MAPK13MAPK12MAPK11MAPK14RAF1 | |
| SCHEMBL14124514 | 0.86 | MAPK13 (0.64) | MAPK13MAPK12MAPK11MAPK14RAF1 | |
| SCHEMBL14060614 | 0.86 | MAPK13 (0.55) | MAPK13MAPK12MAPK11MAPK14RAF1 | |
| SCHEMBL31305575 | 0.86 | MAPK13 (0.55) | MAPK13MAPK12MAPK11MAPK14RAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6551710-B1 | Primer composition comprises dithiol or polythiol compound and allyl or vinyl monomer; coating composition can further comprise photochromic dyes and additional polymerizable monomers; coatings for lenses | SOLA INTERNATIONAL HOLDINGS, LTD. (AU) | 2003-04-22 | — | — | US | claimed |
| WO-1999038924-A1 | COATING COMPOSITION | SOLA INTERNATIONAL HOLDINGS LTD. (AU) | 1999-08-05 | — | — | WO | claimed |
| EP-0842236-A4 | PHOTOCHROMIC POLYMER | SOLA INT HOLDINGS (AU) | 1998-10-21 | — | — | EP | claimed |
| EP-0842236-A1 | PHOTOCHROMIC POLYMER | SOLA INTERNATIONAL HOLDINGS, LTD. (AU) | 1998-05-20 | — | — | EP | claimed |
| WO-1997027223-A1 | PROCESS FOR PREPARING OPTICAL ARTICLES | SOLA INTERNATIONAL HOLDINGS LTD. (AU) | 1997-07-31 | — | — | WO | claimed |
| WO-1997005213-A1 | PHOTOCHROMIC POLYMER | SOLA INTERNATIONAL HOLDINGS LTD. (AU) | 1997-02-13 | — | — | WO | claimed |
| US-12600879-B2 | Coated lens and method for manufacturing the same | CARL ZEISS VISION INTERNATIONAL GMBH (DE) | 2026-04-14 | — | — | US | disclosed |
| EP-4493966-A2 | COATED LENS AND METHOD FOR MANUFACTURING THE SAME | Carl Zeiss Vision International GmbH (DE) | 2025-01-22 | — | — | EP | disclosed |
| US-20240417588-A1 | COATED LENS AND METHOD FOR MANUFACTURING THE SAME | CARL ZEISS VISION INTERNATIONAL GMBH (DE) | 2024-12-19 | — | — | US | disclosed |
| WO-2023175193-A2 | COATED LENS AND METHOD FOR MANUFACTURING THE SAME | CARL ZEISS VISION INTERNATIONAL GMBH (DE) | 2023-09-21 | — | — | WO | disclosed |
| US-11754860-B2 | Photochromic lens with laminated film, method for producing a photochromic lens, and a spectacle frame | CARL ZEISS VISION INTERNATIONAL GMBH (DE) | 2023-09-12 | — | — | US | disclosed |
| CN-116157741-A | Transfer film, method for producing laminate, and method for producing circuit wiring | 富士胶片株式会社 | 2023-05-23 | — | — | CN | disclosed |
| US-20210156739-A1 | Wearable UV Exposure Sensor | BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT | 2021-05-27 | — | — | US | disclosed |
| EP-0797786-A4 | INCORPORATING PHOTOCHROMIC MOLECULES IN LIGHT TRANSMISSIBLE ARTICLES | SOLA INT HOLDINGS (AU) | 1998-12-09 | — | — | EP | disclosed |
| EP-0797786-A1 | INCORPORATING PHOTOCHROMIC MOLECULES IN LIGHT TRANSMISSIBLE ARTICLES | SOLA INTERNATIONAL HOLDINGS, LTD. (AU) | 1997-10-01 | — | — | EP | disclosed |
| WO-1997027223-A1 | PROCESS FOR PREPARING OPTICAL ARTICLES | SOLA INTERNATIONAL HOLDINGS LTD. (AU) | 1997-07-31 | — | — | WO | disclosed |
| WO-1996018928-A1 | INCORPORATING PHOTOCHROMIC MOLECULES IN LIGHT TRANSMISSIBLE ARTICLES | SOLA INTERNATIONAL HOLDINGS LTD. (AU) | 1996-06-20 | — | — | WO | disclosed |
| WO-1996018927-A1 | A PHOTOCHROMIC LIGHT-TRANSMISSIBLE ARTICLE | SOLA INTERNATIONAL HOLDINGS LTD. (AU) | 1996-06-20 | — | — | WO | disclosed |
| EP-0320900-B1 | PROCESS FOR PREPARING NEGATIVE IMAGES ON A POSITIVE-TYPE TONABLE PHOTOSENSITIVE ELEMENT | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-08-04 | — | — | EP | disclosed |
| EP-0320900-A2 | Process for preparing negative images on a positive-type tonable photosensitive element | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600879-B2 | Coated lens and method for manufacturing the same | GMFG, AQP4, METTL14 | MAPK13 3090/4885MAPK12 3727/4885MAPK11 3629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.